Hemant Dhamne

Head of Process Development – Gene Therapy Vector Facility • King’s College London

Dr. Hemant Dhamne is an expert in the field of cell and gene therapy with specific experience in building and operating Product, Process, Analytical Development, and Manufacturing functions.

He has done a Ph.D. in Viral Vectors/Gene Therapy followed by a Postdoc in Functional Genomics. Later he has worked with Intas Pharmaceuticals for AAV Gene Therapy and most recently with Immuneel Therapeutics for CAR-T cell therapy. He also holds a diploma in International Business and Medical Diagnostics. At present, he is heading the Process Development function at Gene Therapy Vector Facility, King’s College London.

He has previously led the team delivering pre-IND & IND applications for AAV-8 FIX, AAV8-FVIII, and CD19-CAR T products. He built the capability and infrastructure for cell and gene therapy in India and was the key person to bring the CGT wave to his country.

Besides this, Hemant also indulges in Indian classical music, learning vocals and bamboo flute.

Also speaking

Mustafa Munye

Director R&D Operations • Complement Therapeutics

Amir Hefni

Worldwide Commercial and Region Europe Head for Cell & Gene • Novartis

Ohad Karnieli

Founder & CEO • Adva Biotechnology

Event Info


Spotlight Roundtables

Take a look at the sample attendee list for Advanced Therapies Europe here.

Pub & Pints RSVP

Let us know you’re planning on attending.